Curated GI articles Apr 15th, 2021: Capital Digestive Care Announces Transaction with Virginia group. Expands to 128 GI providers

Curated GI articles Apr 15th, 2021: Capital Digestive Care Announces Transaction with Virginia group. Expands to 128 GI providers

Curated GI articles Apr 15th, 2021:
Capital Digestive Care Announces Transaction with Virginia group. Expands to 128 GI providers
Capital Digestive Care Announces Transaction with Gastrointestinal & Liver Specialists of Tidewater, PLLC (GlobeNewswire)
Transaction will add 8 locations in Southeastern Virginia, bringing the total number of specialized GI providers to 128 across the Mid-Atlantic Region.
Exact Sciences Completes Acquisition of Ashion Analytics, LLC  (PR Newswire)
The acquisition will incorporate Ashion’s team and help advance Exact Sciences’ precision oncology portfolio.
7 recent reports on interventional endoscopy (Healio)
These reports include new research in adenoma detection, the impact of COVID-19 on colonoscopy capacity and endoscopy-related injuries among GIs.
GI procedures and devices: 6 updates (Becker’s GI & Endoscopy)
Here are six recent updates on gastroenterology procedures and devices.
Breath Analysis Fairly Accurate For Detecting Gastric Cancer (Gastroenterology & Endoscopy News)
Breath testing has the potential to dramatically improve the efficiency of screening for gastric cancers, according to a recent assessment of the approach.
Machine Vision, Robots, and Endoscopes with Matt Schwartz (Out-Of-Pocket)
Interview with Matt Schwartz, the co-founder and CEO of Virgo. Virgo’s mission is to improve patient outcomes and clinical workflows in healthcare by developing automation and AI tools for endoscopy.
Low-dose aspirin suppresses colorectal polyp recurrence (Healio)
Low-dose aspirin suppressed the recurrence of colorectal polyps in patients with familial adenomatous polyposis, according to research in The Lancet.
OncXerna Therapeutics Provides New Results from its Xerna™ RNA-based Biomarker Platform 
(OncXerna Therapeutics)
Xerna™ TME Panel describes the tumor microenvironmnent based on dominant biology subtypes with prognostic capabilities in colorectal cancer.
Colorectal Cancer Survivors Ask: What Can I Do Now? (Gastroenterology & Endoscopy News)
Gastroenterologists can and should guide survivors of colorectal cancer toward lifestyle choices that will reduce their risk for recurrence and death from the disease. But how?
Ingestible Technologies for Diagnosis of Gastrointestinal Disorders (Technology Networks)
Progenity is applying a multi-omics approach to its development of a novel pipeline of precision medicine products designed to provide solutions for gastrointestinal disorders.
U.S. Vaccine Panel Delays Vote on J&J Covid-19 Shot’s Blood-Clotting Risk (The Wall Street Journal)
CDC advisory group says it wants more data and plans to meet again soon on the issue. The Advisory Committee on Immunization Practices expects to meet again in another week or two to revisit the issue.
Nvidia collaborates with AstraZeneca, University of Florida on AI-driven drug discovery (Fierce Healthcare)
The MegaMolBART drug discovery model being developed by Nvidia and AstraZeneca is slated for use in reaction prediction, molecular optimization and de novo molecular generation.
Fecal immunochemical testing increases CRC screening, diagnoses (Healio)
Increased use of fecal immunochemical testing correlated with more colorectal cancer screenings and early-stage diagnoses amid the COVID-19 pandemic, according to research in JAMA Network Open.
Mayo Clinic Launches Joint Ventures to Create and Commercialize AI Diagnostic Tools (BioSpace)
The two new tech companies designed to harness AI and medical algorithms and create “software as medical devices” that clinicians can use to improve treatment across different diseases.
Microsoft Makes Big Bet on Health-Care AI Technology With Nuance (Bloomberg)
The software giant is set to buy Nuance Communications Inc., to overhaul solutions that free doctors from note-taking & better predict a patient’s needs.
Colorectal cancer deaths estimated in 2021: A state-by-state breakdown (Becker’s GI & Endoscopy)
Colorectal cancer is the third leading cause of cancer-related deaths in the United States, and CRC screening procedures dropped more than 80% in the early stages of the pandemic.
Congress passes Medicare sequester fix, now heads to President Biden (Fierce Healthcare)
The House passed the legislation 384-38 on Tuesday that pauses a 2% cut on Medicare payments through the rest of the year.
The mystery of Michigan’s overwhelming Covid surge (CNN)
Michigan is now in the midst of an overwhelming surge that began about six weeks ago. Daily cases are nearing their highest highs; and has by far the highest rate of new infections of any state (510.5 per 100,000 population).

More Hot headlines in GI

Dr. Scott Ketover: “The future of GI remains bright. Because if it goes in your mouth, it’s in our domain” (Interview) (NextServices)

New ACG IBS Guidelines with Brian E. Lacy, MD, PhD (Healio)

A timeline of COVID-19 aid for ASCs (Becker’s ASC Review)

Effect of COVID-19 on the detection and management of colorectal cancer in England (The Lancet)

Bariatric Surgery May Cut Cancer in Obesity With Liver Disease (Medscape)

Food as Medicine in the Management of Common Upper Gastrointestinal Symptoms  (AJG)

11 states projected have the most new colon, rectum cancer cases in 2021
(Becker’s GI & Endoscopy)

COVID-19 infection manifesting as a severe gastroparesis flare: A case report (DocWire News)

Top Takeaways from the 2021 ONC Annual Meeting (Healthcare IT Answers)

Hospital sues gastroenterologists attempting to exit contracts: 5 details (Becker’s GI & Endoscopy)

Fitbit unveils health equity research initiative: 4 details (Becker’s Health IT)

VIDEO: Website provides up-to-date data from NASH cirrhosis study (Healio)

Does Public Policy Affect Alcohol-Related Liver Disease Deaths? (Michigan Health Lab)

Videos: Interviews with GI Leaders  (NextServices)

COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.

Write a Comment